Discontinued
High Outlier
Strength
4 mg/1
Manufacturer
Allergan, Inc.NDC
00023614730
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Last Updated
5/21/2025
Active Ingredients
SILODOSINApproval Type
New Drug (NDA)
FDA Application
NDA022206On Market Since
3/23/2009
Pharmacological Classes
Adrenergic alpha-Antagonists
alpha-Adrenergic Blocker
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.